AzurRx BioPharma
-$0.0338 (-3.81%) Today
+$0.0078 (+0.92%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell AZRX and other stocks, options, and ETFs commission-free!
About AZRX
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Its product programs include MS1819, FW-1022: COVID-19 GI infections, and FW-420: Immune Checkpoint Inhibitor Colitis.
CEO
James E. Sapirstein
Employees
12
Headquarters
Delray Beach, Florida
Founded
2014
AZRX Key Statistics
Market Cap
67.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
880.85K
High Today
$0.90
Low Today
$0.8522
Open Price
$0.88
Volume
720.94K
52 Week High
$2.63
52 Week Low
$0.6501
AZRX Earnings
-$0.46
-$0.31
-$0.15
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13